bepridil has been researched along with Carcinoma, Squamous Cell of Head and Neck in 1 studies
Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.
Excerpt | Relevance | Reference |
---|---|---|
"Taking the intersection part of 27 HNSCC-related Kyoto Encyclopedia of Genes and Genomes pathways and 33 drug-affected pathways, we retained 22 candidate drugs corresponding to two key pathways (cell cycle and p53 signaling pathways) of the five overlapping pathways." | 1.51 | Drug repositioning in head and neck squamous cell carcinoma: An integrated pathway analysis based on connectivity map and differential gene expression. ( Chen, G; Gao, L; Liang, LB; Lin, P; Tang, ZY; Wei, GG; Zeng, JJ; Zhang, LC, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wei, GG | 1 |
Gao, L | 1 |
Tang, ZY | 1 |
Lin, P | 1 |
Liang, LB | 1 |
Zeng, JJ | 1 |
Chen, G | 1 |
Zhang, LC | 1 |
1 other study available for bepridil and Carcinoma, Squamous Cell of Head and Neck
Article | Year |
---|---|
Drug repositioning in head and neck squamous cell carcinoma: An integrated pathway analysis based on connectivity map and differential gene expression.
Topics: Antineoplastic Agents; Bepridil; Boronic Acids; Computational Biology; Drug Repositioning; Gene Expr | 2019 |